Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer’s CD22-targeted cancer drug inotuzumab wins an accelerated OK at FDA
Endpoints
Thu, 08/17/17 - 11:52 pm
Tags:
Pfizer, inotuzumab ozogamicin, acute lymphoblastic leukemia
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
Tags:
patents, AbbVie, Humira, Pfizer, Lipitor, Norvasc, GSK, Advair, Sanofi, Lantus, JNJ, Remicade, AstraZeneca, Crestor, Nexium, Amgen, Neulasta, Novartis, Diovan
Pfizer’s Declining-Revenue Products in 2Q17
Market Realist
Tue, 08/15/17 - 09:33 am
Tags:
Pfizer, Prevnar, Enbrel, Zyvox, Viagra
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
Mon, 08/14/17 - 10:03 am
Tags:
biotech, M&A, JNJ, Actelion, Takeda, Ariad Pharmaceuticals, Gilead Sciences, Pfizer, Amgen
Amgen falls short in Epogen patent appeal but Pfizer stumble delays competition
Fierce Pharma
Fri, 08/11/17 - 11:22 am
Tags:
Amgen, Epogen, patents, Pfizer, anemia, biosimilars
Pharma's giants, new and old, tell more tales than their numbers show
Fierce Pharma
Fri, 08/11/17 - 11:16 am
Tags:
Big Pharma, JNJ, Pfizer, GSK, Roche, Novartis, Sanofi, Bristol-Myers Squibb
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
Tags:
pharma stocks, Merck, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, GSK, Roche, Sanofi, Bayer, Novo Nordisk, Celgene, Biogen, AstraZeneca
Pfizer commits $100M for a gene therapies plant in North Carolina
Fierce Pharma
Thu, 08/10/17 - 10:45 am
Tags:
Pfizer, gene therapy, drug manufacturing, North Carolina
New Novartis rival Kisqali hasn't slowed down Pfizer's Ibrance—at least not yet
Fierce Pharma
Mon, 08/7/17 - 01:32 pm
Tags:
Novartis, Kisqali, Pfizer, Ibrance, breast cancer
Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
TheStreet.com
Sun, 08/6/17 - 09:50 pm
Tags:
Pfizer, earnings, Allergan, M&A
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Endpoints
Fri, 08/4/17 - 11:41 am
Tags:
Pfizer, AstraZeneca, Big Pharma, biotech
Expecting Big Pharma buyers to come running after weakened AstraZeneca? Not so fast
Fierce Pharma
Tue, 08/1/17 - 11:12 pm
Tags:
AstraZeneca, M&A, Pfizer
12 Numbers in Pfizer's Q2 Update More Important Than Its Revenue Decline
Motley Fool
Tue, 08/1/17 - 11:07 pm
Tags:
Pfizer, earnings
Awaiting tax reform clarity, Pfizer delays potential M&A
Drug Delivery Business News
Tue, 08/1/17 - 10:59 pm
Tags:
taxes, Pfizer, M&A
Pfizer (PFE) Surpasses Q2 Earnings Estimates, Misses Sales
Yahoo/Zacks.com
Tue, 08/1/17 - 11:02 am
Tags:
Pfizer, earnings
Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases
Fierce Pharma
Tue, 08/1/17 - 10:58 am
Tags:
Bristol-Myers Squibb, Pfizer, Eliquis, bloodthinners
Earnings Preview: What To Expect From Pfizer On Tuesday
Forbes
Mon, 07/31/17 - 09:44 am
Tags:
Pfizer, earnings
AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment
TheStreet.com
Thu, 07/27/17 - 11:56 am
Tags:
AstraZeneca, Mystic, clinical trials, M&A, Pfizer, Merck
Lilly's baricitinib setback gives Pfizer's Xeljanz a clear shot at newer rivals
Fierce Pharma
Wed, 07/26/17 - 10:33 pm
Tags:
Eli Lilly, baricitinib, Pfizer, Xeljanz, bloodthinners
Merck undercuts Pfizer on Remicade biosimilar price
BioPharma Dive
Wed, 07/26/17 - 10:18 pm
Tags:
Merck, Pfizer, Remicade, drug pricing, biosimilars, Renflexis, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.